Clinical Trials Logo

Anemia, Iron Deficiency clinical trials

View clinical trials related to Anemia, Iron Deficiency.

Filter by:

NCT ID: NCT04812873 Completed - Clinical trials for Iron Deficiency Anemia

Registry Study of ID & IDA in Korean Patients With Heart Failure

HFRegistry
Start date: January 30, 2019
Phase:
Study type: Observational

The prevalence of Iron Deficiency and Iron Deficiency Anemia in Korean HF patient

NCT ID: NCT04782986 Completed - Clinical trials for Iron Deficiency Anemia

Pan-intestinal Capsule Endoscopy Versus Colonoscopy in Iron Deficiency Anemia or Overt GI Bleeding

Start date: June 19, 2020
Phase: N/A
Study type: Interventional

The authors hypothesize that in patients with iron deficiency anemia or gastrointestinal bleeding, pan-intestinal capsule endoscopy is a safe and well tolerated procedure that may improve diagnostic yield comparatively to the current standard invasive colonoscopy.

NCT ID: NCT04751994 Completed - Iron-deficiency Clinical Trials

Iron Babies Pilot Supplementation Trial

Iron Babies
Start date: August 3, 2021
Phase: Phase 3
Study type: Interventional

2-arm, double blind, placebo controlled, randomised trial, with 50 6-week-old infants per arm randomized to 98 days of daily iron (1.5mg/kg/day as ferrous sulphate) or placebo drops

NCT ID: NCT04749589 Completed - Colorectal Cancer Clinical Trials

Fatigue, Quality of Life, Cognitive Function and Physical Ability in Patients Suspected of Colorectal Malignancy

Start date: February 11, 2021
Phase:
Study type: Observational

The aim is to investigate if iron deficiency at the time of colorectal cancer diagnosis has an influence on fatigue, quality of life, cognition and physical ability.

NCT ID: NCT04744818 Completed - Clinical trials for Iron Deficiency Anemia

Effects of Iron Supplementation on Pediatric Vaccine Response

VINO
Start date: February 7, 2021
Phase: N/A
Study type: Interventional

ID/IDA affects many young children in Africa. Vaccines provide tremendous benefits in LMIC; however, they currently fail to reach their full potential. We need to better understand the causes of vaccine failure, in order to develop new strategies to improve vaccine immunogenicity. This study will contribute to children's health by: (1) providing updated guidelines to better define the prevalence of ID/IDA in early infancy, and its safe and effective control using iron; and (2) providing a new approach to improve response to pediatric vaccines in LMIC, by ensuring adequate iron status at time of vaccination.

NCT ID: NCT04744181 Completed - Anemia Clinical Trials

Patient Blood Management In CARdiac sUrgical patientS

ICARUS
Start date: January 18, 2021
Phase:
Study type: Observational

Nowadays up to 40% of patients undergoing cardiac surgery receives at least 1 unit of red blood cell transfusion during surgery or during the first week after surgery. Moreover up to 40% of these patients shows an absolute or relative iron deficiency, with or without anaemia. The objective of this study is to assess whether to implement an adequate correction of iron according to current "patients blood management" recommendations might reduce RBC transfusion requirements in patients undergoing heart surgery. Data obtained in patients included in the study will be compared to those of a case-control population selected from patients consecutively treated at the same department in the previous 2 years.

NCT ID: NCT04735848 Completed - Clinical trials for Iron Deficiency (Without Anemia)

Plasma Hepcidin Response to Differently Dosed Iron Supplements

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The study participants will take 3 different doses of iron supplements at 8 am, on 3 different days. By taking blood samples in the morning and afternoon, the investigators will determine the effects of the iron supplements on plasma hepcidin and compare them to baseline plasma hepcidin values.

NCT ID: NCT04721964 Completed - Clinical trials for Iron Deficiency Anemia

Evaluation of the Effects of Routine Iron Supplementation in Children on Gastrointestinal Iron Losses

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

Iron deficiency anaemia (IDA) is common among infants and young children in sub-Saharan Africa.Oral iron administration is usually recom-mended as cost effective measure to prevent and treat iron deficiency (ID) and IDA during childhood. In Kenya, national nutrition policies for anaemia prevention recommend a daily dose of 3-6 mg ele-mental iron per kg body weight if a child is diagnosed with anaemia. Using a novel technology, recent research found increased iron losses during iron supplementation. In an explorative analysis of stool samples collected from Gambian toddlers (Speich et al., 2020), an increase in faecal iron losses during iron supplementation was reported. The present study is aiming to analyse a relationship between routine iron supplementation and increased faecal occult blood losses in 24 Kenyan children with anaemia and iron deficiency in a more structured manner. Secondary objectives of the study are to measure and monitor iron and inflammatory status during the course of the study and to quantify long-term iron absorption and iron losses during a 12-weeks iron supplementation period, in order to put iron balance into relationship to occurring faecal occult blood losses during such an intervention.

NCT ID: NCT04713943 Completed - Iron-deficiency Clinical Trials

Efficacy of >Your< Iron Syrup Supplementation in Children With Dietary Iron Deficiency

IRON-SI
Start date: December 22, 2017
Phase: N/A
Study type: Interventional

The study evaluates the efficacy and safety of >Your< Iron Syrup, a novel iron-containing dietary supplement, in the management of dietary iron deficiency in children. The study is a randomized, double-blind, placebo-controlled intervention conducted in 16 research centers in Slovenia, collectively enrolling 92 eligible children. Eligibility of children for participation in the study will be determined by screening for hemoglobin and ferritin (combined with C-reactive protein) levels in a sample of capillary blood. Eligible children will receive basic dietary advice on how to increase the consumption of dietary iron and will be invited to participate in the study. Enrolled children will be randomized to either >Your< Iron Syrup arm or to placebo arm in a 3:1 ratio, respectively. Changes in body iron stores (ferritin) and in hematological indices as well as occurence of any adverse events will be monitored after 4 and 12 weeks of once-daily supplementation with either >Your< Iron Syrup or placebo.

NCT ID: NCT04705662 Completed - Clinical trials for Iron Deficiency Anemia

GI Effects of Iron in Healthy Volunteers

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Over recent years there has been a lot of research looking at how the bacteria in our gut affects our health. Some medications are known to cause changes in gut bacteria. Many patients that are prescribed iron report gastrointestinal side effects. This research project aims to see if the cause of the gastrointestinal side effects is due to iron causing changes in the gut bacteria. This can be detected via measuring the levels of hydrogen and methane and other compounds in the breath and stool.